AGENUS INC Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AGENUS INC stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $234.00K, a 800.00% increase year-over-year.
- AGENUS INC stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $1.39M, a 3474.36% increase year-over-year.
- AGENUS INC stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $336.00K.
- AGENUS INC stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $26.00K.
- AGENUS INC stock issued during period, value, issued for services for fiscal 2025 was $1.46M.
- AGENUS INC stock issued during period, value, issued for services for fiscal 2023 was $690.00K, a 400.00% increase from fiscal 2022.
- AGENUS INC stock issued during period, value, issued for services for fiscal 2022 was $138.00K, a 36.11% decline from fiscal 2021.
- AGENUS INC stock issued during period, value, issued for services for fiscal 2021 was $216.00K, a 76.21% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $234.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $1.39M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $1.46M 10-K · filed 2026-03-16 | |
| 2025-09-30 | $336.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $26.00K 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $39.00K 10-Q · filed 2026-08-07 | |
| 2023-12-31 | $690.00K 10-K · filed 2026-03-16 | |
| 2023-09-30 | $312.00K 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $318.00K 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $138.00K 10-K · filed 2025-03-17 | |
| 2022-09-30 | $19.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $20.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $81.00K 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $216.00K 10-K · filed 2024-03-14 | |
| 2021-09-30 | $24.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $31.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $20.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $908.00K 10-K · filed 2023-03-16 | |
| 2019-12-31 | $81.00K 10-K · filed 2022-03-01 | |
| 2014-12-31 | $119.77K 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |